Western Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
French, Craig
BoneZone, NCT04608630 / ACTRN12621000085875p: Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Recruiting
2
450
RoW
Denosumab 60 MG/ML, Prolia, Xgeva, Zoledronic Acid 5Mg/Bag 100Ml Inj, Zometa, Reclast, Aclasta, Sodium Chloride 0.9% or 5% Dextrose Intravenous, Saline, Placebo, Sodium Chloride 0.9% Injection
Australian and New Zealand Intensive Care Research Centre, Department of Health
Critical Illness, Osteoporosis
02/27
02/27
Wijeratne, Tissa
POST-ETERNAL, NCT05105633: Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

Recruiting
2/3
688
RoW
Tenecteplase, Standard Care (which may include intravenous Alteplase)
University of Melbourne
Basilar Artery Occlusion
08/26
12/26
Wong, Shirley S
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
PRAGMATIC, NCT06510699: Pharmacogenomics for Better Treatment of Fungal Infections in Cancer

Not yet recruiting
2
104
US, RoW
genotype-directed dosing with dosing software based on therapeutic drug monitoring, genotype directed with dosing software
The University of Queensland, Metro North Hospital and Health Service, Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, University of Sydney, Western Sydney Local Health District, Sydney Children's Hospitals Network, Peter MacCallum Cancer Centre, Australia, University of Melbourne, Queensland Children's Hospital, Royal Adelaide Hospital, Pathology Queensland, Royal Brisbane and Women's Hospital
Fungal Infection, Haematological Malignancy, Blood Cancer, Infectious Disease
06/26
09/26
JAVELIN Bladder Medley, NCT05327530: A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma

Active, not recruiting
2
256
Europe, Canada, US, RoW
Avelumab, MSB0010718C, Sacituzumab Govitecan, IMMU-132, Trodelvy™, GS-0132, M6223, NKTR-255
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar Therapeutics
Locally Advanced or Metastatic Urothelial Carcinoma
01/25
01/25
INTERVAL, NCT02730338: INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer ( - GAP4)

Active, not recruiting
N/A
866
Europe, Canada, US, RoW
High intensity aerobic and resistance training, Psychosocial support
Movember Foundation, University of California, San Francisco, Edith Cowan University, King's College London, Centre hospitalier de l'Université de Montréal (CHUM)
Metastatic Prostate Cancer
10/25
10/26
Arachchi, Niranjan JS
No trials found

Download Options